Skip to content

Effect of controlled low central venous pressure on postoperative delirium in patients undergoing laparoscopic hepatectomy

Effect of controlled low central venous pressure on postoperative delirium in patients undergoing laparoscopic hepatectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093052
Enrollment
Unknown
Registered
2024-11-27
Start date
2024-03-07
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Group L:Fluid restriction, head-high-feet-low position, and the use of vasodilators or diuretics were used to reduce CVP, resulting in a CVP of <5 cmH2O in patients in group L before the start of hepa
Group N:No CVP-lowering strategy was adopted, fluid infusion was performed according to the principles of rehydration, and CVP was maintained at 5-12 cmH2O intraoperatively.

Sponsors

Hainan General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.ASA ?~?; 2.Child-Pugh A-B; 3.Age 18-65 years 4.Patients undergoing elective laparoscopic hepatectomy; 5.Patients who are able to understand the process and methods of this study and who volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Those who refused to participate in this study; 2. Those who have contraindications to general anesthesia or have had previous accidents with general anesthesia; 3.Patients with known allergies or contraindications to any of the drugs used in the study; 4.Hemoglobin (Hb) 35 kg/m^2 or 178 µmol/L); 7. Patients with uncontrolled hypertension, hypotension and diabetes mellitus; 8.Patients with a previous history of schizophrenia, epilepsy or Parkinson's disease; 9. Patients with visual, auditory, speech, or other impairments that impede communication and delirium assessment; 10.Patients with a history of cerebral infarction, cerebrovascular malformation, traumatic brain injury, or neurosurgery; 11. Patients with severe heart disease, including active coronary artery disease, severe valvular stenosis, and hypertrophic obstructive cardiomyopathy; 12. Patients who are pregnant or breastfeeding; 13. Patients with a history of alcoholism or drug dependence; 14. Patients abusing or chronically applying anesthetic, sedative, analgesic drugs; 15.Patients who have participated in other studies in the last 2 months; 16.Subjects with factors that, in the opinion of other investigators, make participation in this trial inappropriate.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium within 7 days after surgery;

Secondary

MeasureTime frame
Cerebral oxygen saturation;Jugular venous oxygen saturation (SjvO2), cerebral oxygen uptake rate (CERO2), cerebral blood flow/cerebral metabolism of oxygen ratio (CBF/CMRO), arterial blood lactate leve;Intraoperative bleeding and urine output;Perioperative blood creatinine (Scr), blood urea nitrogen (BUN);Rates of postoperative complications, ICU admissions, ICU stays, and total length of stay within 7 days after surgery;

Countries

China

Contacts

Public ContactDuozhi Wu

Hainan General Hospital

13976674619@163.com+86 131 7898 0800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026